Skip to content

Empowered Relief: A One-Time Session to Help Postpartum Women Manage Ongoing Pain After Cesarean Delivery

A Pilot Feasibility Trial for an Intervention to Reduce Chronic Pain Following Cesarean Delivery

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07090018
Enrollment
60
Registered
2025-07-29
Start date
2025-09-25
Completion date
2026-12-31
Last updated
2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Complications, Chronic Pain

Brief summary

The purpose of this study is to study the effect of a pain relief skills session (Empowered Relief) on chronic pain incidence at 12 weeks post cesarean delivery.

Interventions

The participants will attend a pain relief skills intervention (Empowered Relief). The two-hour session is delivered by a certified instructor and includes pain neuroscience education, 3 core pain management skills, experiential exercises, completion of a personalized plan for empowered relief. Participants download a binaural relaxation audio file for daily use.

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Females 18 years of age or older * Any postpartum woman who has had a cesarean delivery in the Stanford Healthcare system with a viable birth * has moderate/severe pain, scoring ≥ 4/10 on the numerical/visual analog scale that continues at 6 weeks postpartum * English fluency * Ability to adhere to and complete study protocols * Access to smart device for zoom / video meetings

Exclusion criteria

* \<18yrs * Chronic pain prior to pregnancy * Cognitive impairment, non-English speaking, or psychological factors that would preclude comprehension of material and/or full participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of participants registering for Empowered Relief sessionBaseline (up to 1 week)
Percentage of participants attending Empowered Relief sessionTreatment (up to 2 weeks)
Participant Satisfaction Scale Score1 - 2 weeks Post treatmentParticipant satisfaction will be measured using a 7 item questionnaire (scale ranges from 0 - 42, higher ratings represent greater satisfaction with the treatment).
Participant Treatment Skills Use Scale Score4 - 6 weeks Post TreatmentParticipant treatment skills use will be measured with a 5 items questionnaire (scale ranges from 0 - 25, higher ratings represent increased time using treatment).

Secondary

MeasureTime frameDescription
Change from baseline in PEG scale score (pain interference)From enrollment to the end of study completion at 6 weeksParticipants complete thrice weekly PEG questionnaire, to assess pain interference via SMS. (Score range 0 - 20, higher score represents a greater degree of interference)
Change from baseline in PROMIS Pain Interference 8a scale scoreBaseline, Week 6Participants complete Patient Reported Outcomes Measurement Outcomes System (PROMIS) Pain Interference 8a questionnaire, an 8-item scale assessing pain interference with life enjoyment, concentration, and daily activities over the past 7 days. (Score range 8 - 40, higher scores represent a greater degree of pain interference).
Response rate to individual items of the PEG scale score via SMSFrom enrollment to the end of study completion at 6 weeksParticipant percentage responding to items of the thrice weekly PEG questionnaire, a 3-item scale assessing pain interference and intensity via SMS. (Score range 0 - 3; higher scores indicate higher response rate)
Change from baseline in PEG scale score (pain intensity)From enrollment to the end of study completion at 6 weeksParticipants complete thrice weekly PEG questionnaire to assess pain intensity, via SMS. (Score range 0 - 10, higher score represents a greater degree of pain intensity)
Change from baseline in PROMIS Pain Intensity 3a scale scoreBaseline, Week 6Participants complete PROMIS Pain Intensity 3a questionnaire, a 3-item scale assessing average pain intensity for the past 7 days. (Score range 3 - 15, higher score represents a greater degree of pain intensity)
Change from baseline in Pain Catastrophizing Scale ScoreBaseline, Week 6Participants complete Pain Catastrophizing questionnaire, a 13-item scale assessing an individual's pain experience (Score range 0 - 52, higher score represents a greater degree of pain catastrophizing)
Change from baseline in PEG scale score (composite)From enrollment to the end of study completion at 6 weeksParticipants complete thrice weekly Pain, Enjoyment, General Activity Scale (PEG) questionnaire, a 3-item scale assessing pain interference and intensity via SMS. (Score range 0 - 30, higher score represents a greater degree of pain intensity/interference)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026